ELE-XX

N/A

Report date: 2025/01/26 19:12:09
NME

Base Information

Drug NameELE-XX
Drug Alias Name5-HT2A agonists (Eleusis Benefit)ELE-XX
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor agonists
TargetsSerotonin 2a (5-HT2a) receptor
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEleusis Therapeutics US Inc
China Registration ClassN/A

Develop Information

Active CompaniesEleusis Therapeutics US Inc
Inactive CompaniesN/A
Active IndicationsInflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A